节点文献

BcL-2、Bax、CD44V6在乳腺癌表达及预后的研究

Study of the expression of BcL-2,Bax and CD44V6 in breast cancer and the prognosis of breast cancer

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 明玉华

【Author】 MING Yu-hua(The People’s Hospital of Yuncheng County,Yuncheng 274700,Shandong,China)

【机构】 山东省郓城县人民医院 山东郓城274700

【摘要】 目的探讨影响乳腺癌患者预后的因素,协助临床制定手术方式及术后治疗方案。方法选择80例各型乳腺癌患者的标本,应用免疫组化SP方法,检测乳腺癌组织中癌基因BcL-2、Bax及黏附因子CD44V6的表达情况。结果乳腺癌中BcL-2、Bax及CD44V6的表达情况与肿瘤组织学分级、瘤体直径。有无转移及患者术后存活时间均有显著性相关(P<0.05或0.01)。结论BcL-2高表达、Bax低表达、CD44V6低表达的患者组织学分级好,肿瘤体积小,淋巴结转移少,术后存活时间长,这部分患者可做肿物扩大切除而保留乳房或即使已做乳房切除,术后也可减少放疗及化疗剂量。

【Abstract】 Objective It is to approach the influencing factors of the prognosis of the breast cancer,and help the clinic to make modus operandi and treatment after surgery.Methods 80 cases of breast cancer with various types were chosen.And the expression of the cancerous genes BcL-2 and Bax,and the conglutinate gene CD44V6 of all cases were checked and measured by the method of SP immunohistochemistry.Results The expression of BcL-2,Bax and CD44V6 of breast cancer had relativity to the grading,tumeur diameter,cancerometastasis and survival time remarkably(P<0.05 or 0.01).Conclusion The tumor is smaller,and the histological grades is well,and the lymph is seldom cancerometastasis,and the survival time is longer which with high expression of BcL-2 and low of Bax and CD44V6.Simultaneity,these patients can save their breast by enlarged resection,or reduces the treatment of radiative or chemic after resection.

【关键词】 乳腺癌BcL-2BaxCD44V6预后
【Key words】 breast cancerBcL-2BaxCD44V6prognosis
  • 【文献出处】 现代中西医结合杂志 ,Modern Journal of Integrated Traditional Chinese and Western Medicine , 编辑部邮箱 ,2007年27期
  • 【分类号】R737.9
  • 【被引频次】3
  • 【下载频次】109
节点文献中: 

本文链接的文献网络图示:

本文的引文网络